NCT00002638View on ClinicalTrials.gov

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 1995

Study Completion Date

March 31, 2005

Conditions

Leukemia

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

sargramostim

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

etoposide

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

68198-3330

University of Nebraska Medical Center, Omaha

All Listed Sponsors

lead

University of Nebraska

OTHER

NCT00002638 - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter